Swadesh K Das Selected Research

Syndecans

1/2021	Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
1/2020	MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
1/2020	MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
1/2019	MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.
1/2018	The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
1/2018	MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells.
10/2017	Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Swadesh K Das Research Topics

Disease

85	Neoplasms (Cancer) 03/2022 - 06/2007
47	Melanoma (Melanoma, Malignant) 01/2022 - 05/2010
19	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2012
12	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2010
12	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2013
11	Glioma (Gliomas) 01/2018 - 10/2011
10	Glioblastoma (Glioblastoma Multiforme) 03/2020 - 08/2013
6	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 01/2014
6	Infections 01/2016 - 05/2010
6	Colonic Neoplasms (Colon Cancer) 10/2012 - 11/2005
4	Neuroblastoma 11/2021 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 12/2005
3	Carcinogenesis 01/2020 - 12/2005
3	Carcinoma (Carcinomatosis) 01/2019 - 11/2005
3	Inflammation (Inflammations) 01/2018 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 04/2012 - 11/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2011
2	Leukemia 03/2020 - 01/2020
2	Liver Neoplasms (Liver Cancer) 01/2020 - 04/2008
2	Adenocarcinoma 01/2015 - 10/2012
1	Experimental Melanoma 01/2022
1	Hypoxia (Hypoxemia) 03/2020
1	Brain Neoplasms (Brain Tumor) 10/2017

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2010
23	SynteninsIBA 01/2021 - 01/2012
20	InterleukinsIBA 12/2021 - 05/2010
16	CytokinesIBA 01/2022 - 05/2010
9	Pharmaceutical PreparationsIBA 11/2019 - 10/2012
8	Interleukin-10 (Interleukin 10)IBA 12/2021 - 05/2010
7	SyndecansIBA 01/2021 - 10/2017
7	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2017
6	AD 5IBA 01/2018 - 05/2012
5	MicroRNAs (MicroRNA)IBA 01/2019 - 06/2010
5	1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamideIBA 06/2015 - 05/2011
4	CateninsIBA 02/2021 - 12/2013
3	Biological ProductsIBA 12/2021 - 01/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 07/2014
3	Beclin-1IBA 01/2018 - 05/2010
3	Tamoxifen FDA LinkGeneric 01/2018 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 03/2008
3	Caspase 3 (Caspase-3)IBA 01/2017 - 01/2013
3	CaspasesIBA 01/2016 - 01/2013
2	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2013
2	interleukin-24 (ST16)IBA 01/2022 - 01/2018
2	InterferonsIBA 12/2021 - 01/2012
2	VinculinIBA 02/2021 - 01/2019
2	Cadherins (E-Cadherin)IBA 02/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2015
2	Interferon-betaIBA 11/2020 - 01/2018
2	mezereinIBA 11/2020 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 03/2020 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2017
2	LigandsIBA 01/2017 - 06/2007
2	EphA2 ReceptorIBA 03/2016 - 07/2014
2	Doxycycline (Periostat)FDA LinkGeneric 11/2015 - 12/2014
2	CarcinogensIBA 11/2015 - 06/2015
2	Celecoxib (Celebrex)FDA Link 06/2015 - 10/2012
2	Messenger RNA (mRNA)IBA 02/2015 - 01/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 01/2012
2	Small Interfering RNA (siRNA)IBA 01/2014 - 06/2010
2	Histone Deacetylase InhibitorsIBA 11/2013 - 08/2013
2	Polyribonucleotide Nucleotidyltransferase (Polynucleotide Phosphorylase)IBA 01/2013 - 06/2010
2	apogossypolIBA 05/2012 - 05/2011
2	Glutamic Acid (Glutamate)FDA Link 10/2011 - 10/2011
2	CalpainIBA 09/2011 - 05/2010
2	CeramidesIBA 09/2011 - 05/2010
2	fucoxanthinIBA 04/2008 - 11/2005
2	Carotenoids (Carotene)IBA 04/2008 - 06/2007
2	Propolis (Bee Bread)IBA 08/2006 - 12/2005
2	artepillin CIBA 08/2006 - 12/2005
1	GATA2 Transcription FactorIBA 03/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	ConnexinsIBA 01/2022
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022
1	Intercalating AgentsIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 12/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	AntigensIBA 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	Lumefantrine FDA Link 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	3- (3- (1H- benzo(d)imidazol- 2- yl)acryloyl)- 6- chloro- 4- phenylquinolin- 2(1H)- oneIBA 01/2019
1	GoldIBA 01/2018
1	Recombinant ProteinsIBA 01/2018
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018
1	SolutionsIBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Liposomes (Liposome)IBA 01/2017

Therapy/Procedure

53	Therapeutics 01/2022 - 06/2007
9	Drug Therapy (Chemotherapy) 01/2021 - 10/2010
3	Immunotherapy 01/2021 - 03/2016
3	Radiotherapy 10/2017 - 03/2015
2	Precision Medicine 02/2021 - 01/2018
2	Microbubbles 01/2018 - 05/2015
2	Chemoprevention 02/2015 - 04/2008
1	Injections 12/2021